Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Using Cryo-Electron Microscopy to Guide the Design of Novel Histone Deacetylase 3 Inhibitors for Cancer Treatment.

EF 2019-20

Résumé
"Cancer is a multi-faceted group of diseases that hijacks the body's cells, causing them to continuously replicate and attack surrounding tissues. In order to control the cell cycle, many cancer cells edit their epigenomes: the pattern of DNA markings that indicate whether or not genes should be actively making protein. The epigenome differs greatly from that of a normal cell due to high expression of epigenetic editor proteins that can interpret, add or remove genetic markings, so called ""readers"", ""writers"" and ""erasers"". In order to edit the epigenome, these editor proteins must be guided to their intended DNA sequence by interactions with other proteins. A guiding protein that tends to be highly expressed in diffuse large B-cell lymphoma is BCL6, which guides the eraser protein HDAC3 to silence genes involved in DNA damage responsiveness. The enhanced silencing program by aberrant BCL6 expression locks immature B-cells in a proliferative state, resulting in cancer. Some success has been had in designing drugs to target human HDACs, but they tend to have off-target effects due to the high number of human HDAC proteins. The goal of my project is to understand how HDAC3 interacts with DNA from an atomic perspective in order to design drugs to selectively target it without targeting other human HDACs, reducing drug toxicity. By using cryogenic transmission electron microscopy, I hypothesize that I will be able to determine a high-resolution image of the HDAC3 protein and those it interacts with to guide the design of novel inhibitors of its erasing function. The inhibition of HDAC3 will serve to help patients with diffuse large B-cell lymphoma by helping to release immature B-cells from their endless proliferation, leading to better, more effective therapies."
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
428895
Name
Kenney Tristan M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Using Cryo-Electron Microscopy to Guide the Design of Novel Histone Deacetylase 3 Inhibitors for Cancer Treatment.
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Biophysics; Cancer; Drug Design; Drug Targeting; Electron Microscopy; Enzyme Mechanisms; Epigenetics; Lymphoma; Model Building; Structural Biology
Abstract
"Cancer is a multi-faceted group of diseases that hijacks the body's cells, causing them to continuously replicate and attack surrounding tissues. In order to control the cell cycle, many cancer cells edit their epigenomes: the pattern of DNA markings that indicate whether or not genes should be actively making protein. The epigenome differs greatly from that of a normal cell due to high expression of epigenetic editor proteins that can interpret, add or remove genetic markings, so called ""readers"", ""writers"" and ""erasers"". In order to edit the epigenome, these editor proteins must be guided to their intended DNA sequence by interactions with other proteins. A guiding protein that tends to be highly expressed in diffuse large B-cell lymphoma is BCL6, which guides the eraser protein HDAC3 to silence genes involved in DNA damage responsiveness. The enhanced silencing program by aberrant BCL6 expression locks immature B-cells in a proliferative state, resulting in cancer. Some success has been had in designing drugs to target human HDACs, but they tend to have off-target effects due to the high number of human HDAC proteins. The goal of my project is to understand how HDAC3 interacts with DNA from an atomic perspective in order to design drugs to selectively target it without targeting other human HDACs, reducing drug toxicity. By using cryogenic transmission electron microscopy, I hypothesize that I will be able to determine a high-resolution image of the HDAC3 protein and those it interacts with to guide the design of novel inhibitors of its erasing function. The inhibition of HDAC3 will serve to help patients with diffuse large B-cell lymphoma by helping to release immature B-cells from their endless proliferation, leading to better, more effective therapies."
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kenney, Tristan M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~